These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23503545)

  • 21. A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling.
    Kovanen L; Basnet S; Castrén S; Pankakoski M; Saarikoski ST; Partonen T; Alho H; Lahti T
    Eur Addict Res; 2016; 22(2):70-9. PubMed ID: 26339899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid antagonist naltrexone for the treatment of pathological gambling in Parkinson disease.
    Bosco D; Plastino M; Colica C; Bosco F; Arianna S; Vecchio A; Galati F; Cristiano D; Consoli A; Consoli D
    Clin Neuropharmacol; 2012; 35(3):118-20. PubMed ID: 22426027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topiramate for the treatment of alcohol dependence: comparison with naltrexone.
    Flórez G; Saiz PA; García-Portilla P; Alvarez S; Nogueiras L; Bobes J
    Eur Addict Res; 2011; 17(1):29-36. PubMed ID: 20975274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study.
    Dannon PN; Lowengrub K; Gonopolski Y; Musin E; Kotler M
    Clin Neuropharmacol; 2005; 28(1):6-10. PubMed ID: 15711432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using topiramate or naltrexone for the treatment of alcohol-dependent patients.
    Flórez G; García-Portilla P; Alvarez S; Saiz PA; Nogueiras L; Bobes J
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1251-9. PubMed ID: 18482157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder.
    Lindley SE; Carlson EB; Hill K
    J Clin Psychopharmacol; 2007 Dec; 27(6):677-81. PubMed ID: 18004136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study.
    Nickel C; Lahmann C; Tritt K; Muehlbacher M; Kaplan P; Kettler C; Krawczyk J; Loew TH; Rother WK; Nickel MK
    J Affect Disord; 2005 Aug; 87(2-3):243-52. PubMed ID: 15985295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
    Behdani F; Hebrani P; Rezaei Ardani A; Rafee E
    Arch Iran Med; 2011 Jul; 14(4):270-5. PubMed ID: 21726104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G; Beeské S; Stahl SM
    J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lorcaserin, phentermine topiramate combination, and naltrexone bupropion combination for weight loss: the 15-min challenge to sort these agents out.
    Citrome L
    Int J Clin Pract; 2014 Dec; 68(12):1401-5. PubMed ID: 25418525
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of naltrexone in pathological and problem gambling: A UK case series.
    Ward S; Smith N; Bowden-Jones H
    J Behav Addict; 2018 Sep; 7(3):827-833. PubMed ID: 30238780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open naltrexone treatment study in pathological gambling disorder.
    Kim SW; Grant JE
    Int Clin Psychopharmacol; 2001 Sep; 16(5):285-9. PubMed ID: 11552772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological management of gambling disorder: an update of the literature.
    Mestre-Bach G; Potenza MN
    Expert Rev Neurother; 2024 Apr; 24(4):391-407. PubMed ID: 38357896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychopharmacological treatment in pathological gambling: a critical review.
    Achab S; Khazaal Y
    Curr Pharm Des; 2011; 17(14):1389-95. PubMed ID: 21524264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of topiramate, bupropion and naltrexone isolated or combined on subcutaneous adipose tissue in obese rats.
    Scudeler MA; Morreale S; Doretto-Silva L; Petri G; Santos JFRD; Nassis C; Correa OMT; Veridiano JM
    Einstein (Sao Paulo); 2022; 20():eAO5587. PubMed ID: 35649051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis: pharmacological treatment of pathological gambling.
    Bartley CA; Bloch MH
    Expert Rev Neurother; 2013 Aug; 13(8):887-94. PubMed ID: 23952195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.